The localization patterns of human plasma lipoproteins and their respective apoproteins and of neutral lipid were determined in normal and atherosclerotic arteries. Specific antisera were prepared against plasma low-density lipoproteins (LDL) and their apoproteins (apoB), high-density lipoproteins (HDL) and one of their major apoproteins (apoA-I), and apoC-III, which is a major apoprotein of very low-density lipoproteins (VLDL). Using immunofluorescence techniques, the various antigens were localized in arterial samples obtained at surgery or autopsy. The three apoproteins and neutral lipid were localized to the same tissue areas, namely, lipid core regions and certain connective tissue of atherosclerotic lesions, in 61% of the fibrous plaques and 48% of the fatty streaks examined. In marked contrast, none of the uninvolved arterial regions showed the presence of all four factors together. As controls, the localization of other serum proteins was also determined in these arteries using immunofluorescence techniques. Fibrinogen was associated with regions of maximum complementary localization of factors in 37% of the fibrous plaques and 64% of the fatty streaks. However, albumin was found in only 4-5% of these same regions. The present results suggest that not only LDL but also HDL and VLDL or their respective apoproteins as well as fibrinogen are specifically retained by certain tissue components of the atherosclerotic lesion.
(HDL), apoB (LDL), and apoC-III (VLDL), employing specific antibodies to these antigens and immunofluorescence techniques. To test for possible specificity of retention in the arterial wall, the same procedures were also used to localize two other serum proteins, namely, fibrinogen and albumin.
Methods
Arteries from a total of 42 subjects between 18 and 75 years old were utilized in this report; they were obtained at autopsy within 24 hours of death (25 subjects) or at surgery (17 subjects). The lipid profiles, age, sex, and other pertinent clinical information are summarized in Table 1 . When lipid determinations were performed, they were carried out 1-2 weeks prior to obtaining the tissue specimens. Segments from the following arteries were obtained at autopsy: the ascending thoracic aorta 3 cm above the aortic valve, the descending abdominal aorta 1 cm below the renal arteries, the origin of the right or the left internal carotid artery, the right coronary artery, the left anterior descending coronary artery, the left circumflex artery, the basilar artery, and the right or the left middle cerebral artery. Segments of right or left carotid bifurcations and of abdominal aortic aneurysms were obtained at surgery. Two to eight segments were excised from each arterial bed and immediately frozen in liquid nitrogen. Areas containing fibrous plaques and fatty streaks and uninvolved regions were chosen for this study. A total of 280 tissue blocks representing 184 fibrous plaques, 56 fatty streaks, and 40 uninvolved regions was examined.
LDL (d 1.020-1.050) and HDL 2 (d 1.063-1.120) were isolated from human normolipemic plasma by conven-
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Circulation Research, Vol. 37, July 1975 (years)   46  53  53  54  55  55  56  56  57  58  60  61  65  67  72  72  75   18  40  41  41  42  46  51  52  53  53  57  57  61  61  63  63  64  64  64  64  70  71  71  72  75   Plasma  cholesterol  (mg/100 ml)   335  299  192  283  244  190  230  284  240  343  290  246  240  269  198  277  286   195  170  355  223  288  199   227  145  385  363  385   121  268  198   199  215   180   133   Plasma  triglycerides  (mg/100 ml)   762  271  505   325  103  265  276  279  132  672  93  123  241  74  113  1568   98   81 tional ultracentrifugation procedures (17) . VLDL (d 1.006) was isolated from type IV or V individuals (18) . Lipid-free VLDL was prepared by delipidation of VLDL with a diethyl-ether-ethanol (3:1) solution at 4°C, and the apoproteins were fractionated on Sephadex G-100 to yield apoB and the apoC proteins (19, 20) . ApoC-III was purified by chromatography of the C-peptides on DEAE cellulose (19, 20) . ApoC-III containing two residues of sialic acid was used in the present study. ApoA-I was obtained by chromatography of lipid-free HDL on Sephadex G-150 in 5.4 M urea (21) . ApoA-I and apoC-III migrated as single bands on polyacrylamide gel electrophoresis in urea (22) and sodium dodecyl sulfate (23) and had amino acid analyses consistent with their known primary structures (24) .
Specific antibodies were prepared against apoB, apoA-I, and apoC-III by immunizing rabbits or goats. Partially purified globulin fractions were obtained by precipitation with 40% ammonium sulfate. Antisera to apoB and LDL were conjugated to fluorescein isothiocyanate, and then the conjugated antisera were further purified by affinity chromatography using LDL coupled to Sepharose as previously described (7) . Antisera to HDL 2 , apoA-I, and apoC-III were also purified by affinity chromatography on Sepharose to which the apoprotein had been covalently coupled. The antisera (1 mg/ml) were stored at -20°C in 0.1% bovine serum albumin. Fluoresceinated preparations of human antifibrinogen and human antialbumin were obtained commercially (Hyland Products). Immunodiffusion techniques were employed to test the monospecificity of each antibody preparation. The specificity of each antiserum is summarized in Table 2 .
Cryostat sections (4/u thick) were incubated with specific antisera for 1 hour at 23° C followed by two 15-minute rinses with 0.1M potassium phosphate buffer containing 0.9% NaCl, pH 7.4; the sections were then mounted in glycerol. To localize HDL 2 , apoA-I, and apoC-III, an indirect method was used which employed a second incubation of the sections with fluoresceinated antibodies that had been prepared against the IgG fraction of the species used to raise that specific antibody, e.g., goat antirabbit IgG. In most studies, it was necessary to use dilutions of the anti-antibody preparation of 10-64 to remove nonspecific fluorescence. All control studies employing nonimmune sera were negative. Oil red O stain was used to visualize neutral lipid. Collagen was localized in sections from most blocks with Van Gieson's or Movat's Pentachrome stains. A Leitz Orthoplan photomicroscope equipped with an HBO 200 w mercury light source, a UG-1 primary filter, a K-430 secondary filter, and a dry dark-field condenser was employed for the fluorescence localization. High-speed Ektachrome and Tri-X film were used for photography.
During the course of this study, it was observed that apoA-I, apoB, apoC-III, and neutral lipid tended to have a complementary localization to connective tissue and lipid cores of plaques ( Fig. 1 ). This pattern was the same as that obtained for apoB previously (7, 8) . To semiquantify the extent of complementary localization of apoproteins and neutral lipid, each tissue block was classified from 0 to 4 according to whether sections from that block contained areas demonstating a maximum complementary localization of 0, 1, 2, 3, or 4 factors. These patterns of complementary localization were also compared to the localization of fibrinogen and albumin. Both the determination of positive fluorescence of certain tissue regions by microscopy and the classification of sections by superposition of localizations were performed independently by two investigators (H. F. H. and C. L. H.) with consistent results. The classification of sections was performed after the localization patterns of each factor had been mapped on a schematic diagram of the artery topography. The specimens were subdivided into three categories: (1) fatty streak lesions, defined in the present paper as areas close to the luminal surface and containing lipid-filled cells and some extracellular lipid associated with connective tissue, (2) fibrous plaque lesions, defined as areas of fibrosis with a necrotic area or a lipid core, and (3) uninvolved areas, which included both normal arteries and arteries with focal or diff&se intimal thickening but without stainable neutral lipid.
The distribution of specimens demonstrating a maximum complementary localization of 0-4 factors was compared in uninvolved arteries, fatty streaks, and fibrous plaques. Statistical analysis was performed using a general linear model for the analysis of categorical data (25) . This method permits the testing of multivariate contrasts by means of statistics which have an asymptotic chi-square distribution.
Initially, the distribution of the specimens was tabulated separately for each arterial bed and for each case. However, the findings were pooled, since the trend for each group matched the pooled results and the numbers for each individual group were too small for statistical evaluation. During the study, it became apparent that utilization of random sections resulted in error due to the focal nature of the changes in arterial structure resulting from the atherosclerotic process. The original protocol was revised in that only two slides, each containing six The specificity of each antiserum was determined using double-gel diffusion techniques. + = positive reaction, and -= negative reaction. Single precipitin lines were obtained between each antigen and antibody well. Antigen and antibody concentrations were tested over concentration ranges of 0.03 to 2.0 mg/ml. Antibodies to apoA-I, apoB, and apoC-III were purified by immunoadsorbents. Fluorescein-protein molar ratios of conjugated antibodies ranged from 1.0 to 1.3. serial sections, were employed. The localizations of apoA-I and apoC-III were both obtained on one slide by covering three sections on the slide with the antibody localization medium for each apoprotein. The second slide was used to localize apoB. Following the evaluation of localization by fluorescence microscopy, the second slide was washed, fixed in Formalin, and stained with oil red 0 to localize neutral lipid. The results using random sections were tabulated as series 1, in which a comparison was also made between the localization of the apoprotein and lipid and that of native HDL, LDL, fibrinogen, and albumin. The results using serial sections form series 2.
Results

The degree of complementary localization of the three apoproteins and neutral lipid was determined
Circulation Research, Vol. 37, July 1975 in the two series of studies. The major areas of complementary localization were bands of collagen and elastic membrane in both fatty streaks and fibrous plaques and the lipid cores of fibrous plaques. Some localization was found several microns within the luminal surface of both uninvolved and atherosclerotic arteries.
In the 162 tissue blocks of series 1 (Table 3) , 46% of the fibrous plaques and 39% of the fatty streaks but none of the uninvolved regions contained areas showing all four factors localized together; 80% of the fibrous plaques and 84% of the fatty streaks but only 13% of the uninvolved areas demonstrated the presence of at least three of the four factors localized to the same region. By contrast, 50% of the uninvolved areas failed to demonstrate the presence of any of the factors, and 30% showed the presence of only one of the four. The distribution of numbers of sections with 0, 1, 2, 3, or 4 complementary localized factors differed significantly (P < 0.01) when either the fatty streaks or the fibrous plaques were compared with the uninvolved regions. The differences between fatty streaks and fibrous plaques were not statistically significant (P > 0.20).
Fibrinogen was found in more than half of the fibrous plaques in either mural thrombi or lipid cores and in 70% of the fatty streaks, usually on the luminal surface, in series 1. Only 26% of the uninvolved arteries demonstrated the presence of fibrinogen. In 37% of the fibrous plaques and 64% of the fatty streaks, fibrinogen was localized to the regions demonstrating maximum complementary localization of apoproteins and lipid. Albumin was found in only 10% of both the fatty streaks and the fibrous plaques; it was not detected in uninvolved areas.
In the 118 tissue blocks of series 2 (Table 4) , 81% of the fibrous plaques and 60% of the fatty streaks but none of the uninvolved areas showed all four factors at the same site; 93% of the fibrous plaques and 80% of the fatty streaks but 0% of the uninvolved areas showed at least three of the four factors together. By contrast, 90% of the uninvolved regions failed to demonstrate any of these factors. As in series 1, the distribution of classifications for both fibrous plaques and fatty streaks in series 2 differed significantly (P < 0.01) from that for uninvolved regions. The distribution of classifications for fatty streaks did not differ significantly from that for fibrous plaques (P > 0.3).
When the distribution of classifications for fibrous plaques, fatty streaks, and uninvolved regions between series 1 and series 2 were compared individually, only the differences for fibrous plaques were statistically significant (P < 0.001). Pooling the data from the two series (Table 5) indicates that 61% of the fibrous plaques, 48% of the fatty streaks, and 0% of the uninvolved regions had areas in which all three apoproteins and neutral lipid were present together; 85% of the fibrous plaques, 82% of the fatty streaks, and 10% of the uninvolved arteries showed at least three of the four factors with complementary localization.
The localization pattern of neutral lipid was usually more widespread in arterial lesions than that of apoproteins, resulting in the presence of some areas in most lesions that were positive for lipid but negative for apoproteins. By contrast, 25% of all of the specimens studied showed some areas positive for apoproteins which were negative for .neutral lipid, but such areas encompassed only a very small part of the total topography. All apoprotein-positive uninvolved specimens were negative for neutral lipid.
The relative frequency with which the factors were localized in all of the sections studied was: neutral lipid > apoB > apoC-III = apoA-I. ApoB was found with apoC-III in 83% of the areas 
Each block was classified from 0 to 4 according to the maximum number of apoproteins (apoA-I, apoB, and apoC-III) and neutral lipid localized in any one area of the tissue. Numbers in parentheses indicate the percent of the total for each category. demonstrating either apoB or apoC-III. The frequency of localization of apoC-III was no higher in arteries from type IV or V hyperlipoproteinemic subjects who had elevated plasma apoC-III levels than it was in arteries from normolipemics. In series 1, apoA-I was localized to the same areas as HDL 2 in 86% of the arteries demonstrating HDL 2 localization. Also in series 1, apoB was localized to the same areas as LDL in 95% of the arteries demonstrating LDL localization. In both series, the frequencies of associations between apoB and apoC-III, apoB and apoA-I, and apoC-III and apoA-I were not significantly different.
Discussion
Antisera to major apoproteins of VLDL (apoC-III), LDL (apoB), and HDL (apoA-I) were used in these studies, since human plasma lipoproteins contain common antigens and cross-react immunologically (16) . Using these specific antisera, it was shown by immunohistochemical techniques that all three antigens were usually localized to the same tissue regions in both fatty streaks and fibrous plaques. In an unpublished study in our laboratory, apoA, apoB, and apoC have all been found in saline extracts of human arterial lesions by double-gel diffusion techniques.
The extracellular localization of apoB in lesions is consistent with the findings from other laboratories (11-15). The presence of the apoC proteins in lesions has been described in a preliminary report (26) . In contrast to the present study, most previous investigations (11-14) have failed to detect the HDL antigens in atherosclerotic lesions, although HDL protein has been demonstrated by gel diffusion techniques in extracts of arterial lesions (5) . In vitro studies (27) have also shown that HDL can be taken up by arteries.
Since anti-apoC-III reacts with both VLDL and HDL, a definitive localization of VLDL is not possible. However, the simultaneous presence of apoB and apoC-III does suggest the presence of some VLDL. It is also conceivable that the localization of apoC-III indicates the presence of VLDL remnant particles in atherosclerotic lesions. Cellular uptake of such particles has been demonstrated in cultured smooth muscle cells (28) , and it has been recently suggested that these particles are Each block was classified from 0 to 4 according to the maximum number of apoproteins (apoA-I, apoB, and apoC-III) and neutral lipid localized in any one area of the tissue. Numbers in parentheses indicate the percent of the total for each category. implicated in the pathogenesis of atherosclerosis (29) .
It appears likely that at least some of the apoproteins localized to extracellular tissue areas are present as part of native lipoproteins, since these apoproteins are usually found together with neutral lipid (14) . But as this study has shown, there are exceptions. Evidence suggesting the presence of native LDL in such lesions has been reported. LDL extracted from human arterial lesions has been shown to have the same lipid composition and density as native LDL (5) . The mechanisms by which lipoproteins are localized to the connective tissue of the plaques and to the lipid cores are unknown. Glycosaminoglycans have been shown to bind LDL and VLDL (30) , and such complexes have been extracted from atherosclerotic lesions (31) . Recent in vitro and in vivo studies have shown that elastin extracted from plaques binds cholesterol esters from LDL, whereas elastin from uninvolved arteries does not (32) . It is conceivable, therefore, that the interaction of lipoproteins with plaque material results from the binding of the lipid moiety rather than the apoproteins with plaque tissue.
The similarity in the localization pattern of fibrinogen and that of the apoproteins and neutral lipid is consistent with immunochemical studies (5) and suggests the possible interaction of fibrinogen with either tissue-or plasma-derived components. The failure to consistently localize albumin with these immunohistochemical techniques in contrast to the findings with immunochemical procedures (5) suggests that not enough albumin has accumulated to be detected by the former techniques. By contrast, apoproteins, either free or together with lipid in the form of lipoproteins, and fibrinogen appear to accumulate in lesions. Whether this net influx is a result of interaction with tissue components or some other mechanism of retention still needs to be clarified.
The results of this study suggest that most atherosclerotic lesions have at least one area demonstrating the simultaneous binding of the three lipoprotein fractions. The results of the second series of studies, which utilized serial sections of specimens, suggest complete complementary localization of apoprotein and lipid. Departure from complete complementary localization of factors may result from the relatively focal nature of different arterial structural changes as a result of the atherosclerotic process.
It has been shown previously that the frequency of positive fluorescence for apoB correlates with the plasma apoB concentration (7) (8) (9) . In the present study, no such correlation was found between plasma and tissue apoC-III as studied in arteries from type IV hyperlipoproteinemics and normolipoproteinemics. Uncontrolled variables associated with immunohistochemical techniques, such as antibody titer, and fluorescein-protein ratios of coupled antibodies, and utilization of both direct and indirect fluorescence techniques precluded quantification in the present report. However, methods to quantify apolipoproteins in atherosclerotic lesions are presently under study.
